NYSE:TFX

Teleflex (TFX) Stock Forecast, Price & News

$237.04

-1.52 (-0.64%)

(As of 06/9/2023 ET)

Compare

Today's Range: $236.20
▼
$239.56
50-Day Range: $232.06
▼
$274.11
52-Week Range: $182.65
▼
$276.43

Volume: 197,583 shs
Average Volume: 228,656 shs
Market Capitalization: $11.12 billion

P/E Ratio: 30.90
Dividend Yield: 0.57%
Price Target: $273.38

Teleflex MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 15.3% Upside
$273.38 Price Target
Short Interest: Bearish
3.58% of Shares Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -1.53
Upright™ Environmental Score
News Sentiment: 0.28
Based on 5 Articles This Week
Insider Trading: Selling Shares
$742,290 Sold Last Quarter
Proj. Earnings Growth: 9.41%
From $13.29 to $14.54 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.31 out of 5 stars

Medical Sector

228th out of 987 stocks

Surgical & Medical Instruments Industry

19th out of 94 stocks

2.3

Analyst's Opinion

Consensus Rating
Teleflex has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 6 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $273.38, Teleflex has a forecasted upside of 15.3% from its current price of $237.04.
Amount of Analyst Coverage
Teleflex has only been the subject of 4 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
3.58% of the outstanding shares of Teleflex have been sold short.
Short Interest Ratio / Days to Cover
Teleflex has a short interest ratio ("days to cover") of 5.1.
Change versus previous month
Short interest in Teleflex has recently increased by 11.26%, indicating that investor sentiment is decreasing significantly.

1.7

Dividend Strength

Dividend Yield
Teleflex has a dividend yield of 0.57%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Teleflex does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Teleflex is 17.73%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Teleflex will have a dividend payout ratio of 9.35% next year. This indicates that Teleflex will be able to sustain or increase its dividend.

3.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Teleflex has received a 53.08% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Wound closure devices", "Surgical clamps", and "Catheters" products. See details.
Environmental Sustainability
The Environmental Impact score for Teleflex is -1.53.

1.3

News and Social Media Coverage

News Sentiment
Teleflex has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Teleflex this week, compared to 6 articles on an average week.
Search Interest
Only 2 people have searched for TFX on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added Teleflex to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Teleflex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $742,290.00 in company stock.
Percentage Held by Insiders
Only 1.41% of the stock of Teleflex is held by insiders.
Percentage Held by Institutions
93.82% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Teleflex are expected to grow by 9.41% in the coming year, from $13.29 to $14.54 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Teleflex is 30.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 143.95.
Price to Earnings Ratio vs. Sector
The P/E ratio of Teleflex is 30.90, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 127.08.
Price to Earnings Growth Ratio
Teleflex has a PEG Ratio of 2.55. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Teleflex has a P/B Ratio of 2.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Teleflex (NYSE:TFX) Stock

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Stock News Headlines

June 8, 2023 | msn.com

Teleflex's (TFX) Wattson Temporary Pacing Receives FDA Nod

June 7, 2023 | finance.yahoo.com

Teleflex Receives FDA Clearance for the Wattson® Temporary Pacing Guidewire

June 10, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

June 6, 2023 | markets.businessinsider.com

Teleflex: FDA Clears Arrow EZ-IO Needle As MR Conditional

June 6, 2023 | finance.yahoo.com

The three-year loss for Teleflex (NYSE:TFX) shareholders likely driven by its shrinking earnings

June 2, 2023 | americanbankingnews.com

Teleflex Incorporated (NYSE:TFX) Receives $269.18 Consensus Target Price from Analysts

June 1, 2023 | msn.com

Premier signs purchasing agreement with Teleflex

June 1, 2023 | americanbankingnews.com

Teleflex (NYSE:TFX) Coverage Initiated at CL King

June 10, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

May 31, 2023 | msn.com

CL King Initiates Coverage of Teleflex (TFX) with Buy Recommendation

May 30, 2023 | msn.com

Expert Ratings for Teleflex

May 18, 2023 | americanbankingnews.com

StockNews.com Begins Coverage on Teleflex (NYSE:TFX)

May 16, 2023 | msn.com

Teleflex's Return on Invested Capital Insights

May 15, 2023 | finance.yahoo.com

Teleflex Publishes 2022 Global Impact Report

May 13, 2023 | americanbankingnews.com

Stuart A. Randle Sells 3,021 Shares of Teleflex Incorporated (NYSE:TFX) Stock

May 11, 2023 | americanbankingnews.com

Teleflex (NYSE:TFX) Upgraded at StockNews.com

May 10, 2023 | marketwatch.com

Teleflex Inc. stock falls Wednesday, underperforms market

May 10, 2023 | marketwatch.com

Teleflex Inc. stock outperforms competitors on strong trading day

May 10, 2023 | msn.com

Raymond James Maintains Teleflex (TFX) Outperform Recommendation

May 10, 2023 | msn.com

Teleflex (TFX) Declares $0.34 Dividend

May 9, 2023 | finance.yahoo.com

An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 20% Undervalued

May 9, 2023 | americanbankingnews.com

Teleflex Incorporated to Post Q2 2023 Earnings of $3.15 Per Share, KeyCorp Forecasts (NYSE:TFX)

May 8, 2023 | americanbankingnews.com

Brokerages Set Teleflex Incorporated (NYSE:TFX) Target Price at $273.00

May 6, 2023 | seekingalpha.com

Teleflex Incorporated 2023 Q1 - Results - Earnings Call Presentation

May 4, 2023 | finance.yahoo.com

Teleflex (TFX) Reports Q1 Earnings: What Key Metrics Have to Say

May 4, 2023 | finance.yahoo.com

Teleflex Reports First Quarter Financial Results and Full Year 2023 Outlook

May 3, 2023 | finance.yahoo.com

New Data Highlight that Early Intervention with the UroLift® System Facilitates Long-Term Outcomes for BPH Patients

See More Headlines

TFX Price History

30 days | 90 days | 365 days | Advanced Chart

TFX Company Calendar

Ex-Dividend for 3/15 Dividend: 3/02/2023
Dividend Payable: 3/15/2023
Last Earnings: 5/04/2023
Ex-Dividend for 6/15 Dividend: 5/12/2023
Today: 6/09/2023
Dividend Payable: 6/15/2023
Next Earnings (Estimated): 7/27/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:TFX
CUSIP: 87936910
CIK: 96943
Web: www.teleflex.com
Phone: (610) 225-6800
Fax: 215-553-5402
Employees: 15,500
Year Founded: 1943

Price Target and Rating

Average Stock Price Forecast: $273.38
High Stock Price Forecast: $330.00
Low Stock Price Forecast: $210.00
Forecasted Upside/Downside: +15.3%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 12 Analysts

Profitability

EPS (Most Recent Fiscal Year): $7.67
Trailing P/E Ratio: 30.90
Forward P/E Ratio: 17.84
P/E Growth: 2.55
Net Income: $363.14 million
Net Margins: 12.68%
Pretax Margin: 15.73%
Return on Equity: 15.80%
Return on Assets: 9.18%

Debt

Debt-to-Equity Ratio: 0.38
Current Ratio: 2.48
Quick Ratio: 1.41

Sales & Book Value

Annual Sales: $2.79 billion
Price / Sales: 3.98
Cash Flow: $17.94 per share
Price / Cash Flow: 13.21
Book Value: $85.74 per share
Price / Book: 2.76

Miscellaneous

Outstanding Shares: 46,900,000
Free Float: 46,239,000
Market Cap: $11.12 billion
Optionable: Optionable
Beta: 1.00

Social Links

Key Executives

Mr. Liam J. Kelly (Age 56)
Chairman, Pres & CEO
Comp: $2M

Mr. Thomas E. Powell (Age 61)
Exec. VP & CFO
Comp: $1.04M

Mr. Cameron P. Hicks (Age 58)
Corp. VP of HR & Communications
Comp: $564.68k

Mr. Jay White (Age 49)
Corp. VP & Pres of Global Commercial
Comp: $866.86k

Mr. John R. Deren
Corp. VP & Chief Accounting Officer

Mr. Timothy F. Duffy
VP & Chief Information Officer

Mr. John Hsu C.F.A.
VP of Investor Relations

Mr. Daniel V. Logue (Age 49)
Corp. VP, Gen. Counsel & Sec.

Mr. Howard Cyr
Corp. VP & Chief Compliance Officer

Mr. Matt Tomkin
VP of Corp. Devel.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

TFX Stock - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?: 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TFX shares.
View TFX analyst ratings or view top-rated stocks.
What is Teleflex's stock price forecast for 2023?: 12 brokers have issued 12 month price targets for Teleflex's stock. Their TFX share price forecasts range from $210.00 to $330.00. On average, they anticipate the company's share price to reach $273.38 in the next year. This suggests a possible upside of 15.3% from the stock's current price.
View analysts price targets for TFX or view top-rated stocks among Wall Street analysts.
How have TFX shares performed in 2023?: Teleflex's stock was trading at $249.63 at the beginning of 2023. Since then, TFX shares have decreased by 5.0% and is now trading at $237.04.
View the best growth stocks for 2023 here.
When is Teleflex's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our TFX earnings forecast.
How were Teleflex's earnings last quarter?: Teleflex Incorporated (NYSE:TFX) released its quarterly earnings data on Thursday, May, 4th. The medical technology company reported $3.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.97 by $0.12. The medical technology company earned $710.90 million during the quarter, compared to analysts' expectations of $687.11 million. Teleflex had a net margin of 12.68% and a trailing twelve-month return on equity of 15.80%. The company's revenue for the quarter was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.88 earnings per share.
Read the conference call transcript.
How often does Teleflex pay dividends? What is the dividend yield for Teleflex?: Teleflex announced a quarterly dividend on Monday, May 8th. Investors of record on Monday, May 15th will be given a dividend of $0.34 per share on Thursday, June 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Friday, May 12th.
Read our dividend analysis for TFX.
What ETFs hold Teleflex's stock?: ETFs with the largest weight of Teleflex (NYSE:TFX) stock in their portfolio include First Trust Indxx Medical Devices ETF (MDEV), Invesco S&P 500 Equal Weight Health Care ETF (RYH), SPDR S&P Health Care Equipment ETF (XHE), iShares U.S. Medical Devices ETF (IHI), Mid Cap US Equity Select ETF (RNMC), Global X Aging Population ETF (AGNG), First Trust Health Care AlphaDEX Fund (FXH) and Timothy Plan US Large Cap Core ETF (TPLC).
Is Teleflex a good dividend stock?: Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.57%. The dividend payout ratio is 17.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.35% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What guidance has Teleflex issued on next quarter's earnings?: Teleflex issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided EPS guidance of $13.00-$13.60 for the period, compared to the consensus earnings per share estimate of $13.29. The company issued revenue guidance of $2.92 billion-$2.96 billion, compared to the consensus revenue estimate of $2.93 billion.
What is Liam Kelly's approval rating as Teleflex's CEO?: 73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.
What other stocks do shareholders of Teleflex own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).
What is Teleflex's stock symbol?: Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."
Who are Teleflex's major shareholders?: Teleflex's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.48%), Wellington Management Group LLP (6.60%), State Street Corp (4.96%), Price T Rowe Associates Inc. MD (3.90%), Geode Capital Management LLC (2.07%) and Allspring Global Investments Holdings LLC (1.80%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle.
View institutional ownership trends.
How do I buy shares of Teleflex?: Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Teleflex's stock price today?: One share of TFX stock can currently be purchased for approximately $237.04.
How much money does Teleflex make?: Teleflex (NYSE:TFX) has a market capitalization of $11.12 billion and generates $2.79 billion in revenue each year. The medical technology company earns $363.14 million in net income (profit) each year or $7.67 on an earnings per share basis.
How many employees does Teleflex have?: The company employs 15,500 workers across the globe.
How can I contact Teleflex?: Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402.

This page (NYSE:TFX) was last updated on 6/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial